Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masamichi Eguchi

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Circulation Reports|November 21, 2022
Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism - A Single-Center Retrospective StudyYuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2023
Real-world Safety and Effectiveness of Edoxaban in Patients with Venous Thromboembolism with or without Preceding Parenteral Anticoagulants: A Single-center Retrospective StudyYuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, et al.
Biomedicines|November 6, 2020
Febuxostat, a Xanthine Oxidase Inhibitor, Decreased Macrophage Matrix Metalloproteinase Expression in HypoxiaShuoyu Wei, Takayuki Isagawa, Masamichi Eguchi, et al.
Heart and Vessels|October 21, 2018
Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer and/or older ageDaisuke Sato, Satoshi Ikeda, Seiji Koga, et al.
Circulation Reports|November 11, 2025
Effect of β-Blockers on the Left Ventricular Strain in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy Treated With TafamidisRosy Haruna Nishizawa, Hiroaki Kawano, Chisa Eguchi, et al.
Journal of Cardiology|April 18, 2018
Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancerSatoshi Ikeda, Seiji Koga, Yuki Yamagata, et al.
European Heart Journal. Cardiovascular Imaging|December 18, 2023
Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosisRosy Haruna Nishizawa, Hiroaki Kawano, Tsuyoshi Yoshimuta, et al.
Acta Biomaterialia|October 15, 2022
Regeneration of the ureter using a scaffold-free live-cell structure created with the bio-three-dimensional printing techniqueKatsunori Takagi, Keitaro Matsumoto, Daisuke Taniguchi, et al.
Circulation Reports|July 11, 2025
Comparing Effects of Tafamidis in Controlling Left Ventricular and Left Atrial Strains in Patients With Wild-Type Transthyretin Amyloid CardiomyopathyChisa Eguchi, Hiroaki Kawano, Rosy Haruna Nishizawa, et al.
Circulation Reports|May 11, 2026
Association Between Severe Aortic Stenosis and Amyloid Deposition in the Myocardium of Patients With Wild-Type Transthyretin Cardiac AmyloidosisKentaro Furukawa, Hiroaki Kawano, Ryohei Akashi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Circulation Reports|November 21, 2022
Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism - A Single-Center Retrospective StudyYuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, et al.
Internal Medicine (Tokyo, Japan)|November 19, 2023
Real-world Safety and Effectiveness of Edoxaban in Patients with Venous Thromboembolism with or without Preceding Parenteral Anticoagulants: A Single-center Retrospective StudyYuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, et al.
Biomedicines|November 6, 2020
Febuxostat, a Xanthine Oxidase Inhibitor, Decreased Macrophage Matrix Metalloproteinase Expression in HypoxiaShuoyu Wei, Takayuki Isagawa, Masamichi Eguchi, et al.
Heart and Vessels|October 21, 2018
Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer and/or older ageDaisuke Sato, Satoshi Ikeda, Seiji Koga, et al.
Circulation Reports|November 11, 2025
Effect of β-Blockers on the Left Ventricular Strain in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy Treated With TafamidisRosy Haruna Nishizawa, Hiroaki Kawano, Chisa Eguchi, et al.
Journal of Cardiology|April 18, 2018
Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancerSatoshi Ikeda, Seiji Koga, Yuki Yamagata, et al.
European Heart Journal. Cardiovascular Imaging|December 18, 2023
Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosisRosy Haruna Nishizawa, Hiroaki Kawano, Tsuyoshi Yoshimuta, et al.
Acta Biomaterialia|October 15, 2022
Regeneration of the ureter using a scaffold-free live-cell structure created with the bio-three-dimensional printing techniqueKatsunori Takagi, Keitaro Matsumoto, Daisuke Taniguchi, et al.
Circulation Reports|July 11, 2025
Comparing Effects of Tafamidis in Controlling Left Ventricular and Left Atrial Strains in Patients With Wild-Type Transthyretin Amyloid CardiomyopathyChisa Eguchi, Hiroaki Kawano, Rosy Haruna Nishizawa, et al.
Circulation Reports|May 11, 2026
Association Between Severe Aortic Stenosis and Amyloid Deposition in the Myocardium of Patients With Wild-Type Transthyretin Cardiac AmyloidosisKentaro Furukawa, Hiroaki Kawano, Ryohei Akashi, et al.
Pageof 3